Announced
Financials
Tags
United States
biotechnology
Domestic
Friendly
Public
Majority
Pending
Biotechnology
Single Bidder
Acquisition
Tender Offer
Synopsis
Biomed Industries, a bio-pharmaceutical company, offered to acquire Quince Therapeutics, a biotechnology company focused on acquiring, developing, and commercializing innovative therapeutics, for $90m. "We believe our offer is very compelling as it provides Quince' shareholders with a highly certain and significant return and the ability to obtain liquidity for their shares, as well as the upside potential of Biomed," Lloyd L. Tran, Biomed Industries Chairman and CEO.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.